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Formation of skeletal muscle fibers (myogenesis) during development and after tissue
injury in the adult constitutes an excellent paradigm to investigate the mechanisms
whereby environmental cues control gene expression programs in muscle stem cells
(satellite cells) by acting on transcriptional and epigenetic effectors. Here we will review
the molecular mechanisms implicated in the transition of satellite cells throughout the
distinct myogenic stages (i.e., activation from quiescence, proliferation, differentiation,
and self-renewal). We will also discuss recent findings on the causes underlying satellite
cell functional decline with aging. In particular, our review will focus on the epigenetic
changes underlying fate decisions and on how the p38 MAPK signaling pathway
integrates the environmental signals at the chromatin to build up satellite cell adaptive
responses during the process of muscle regeneration, and how these responses are
altered in aging. A better comprehension of the signaling pathways connecting external
and intrinsic factors will illuminate the path for improving muscle regeneration in the aged.
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INTRODUCTION
The regenerative capacity of adult skeletal muscle depends on a resident population of muscle
stem cells called satellite cells, which are located between the sarcolemma and the basal lamina.
In healthy adult muscles, satellite cells reside in a dormant quiescent state and are characterized
by the expression of the paired-box transcription factor Pax7 (Chang and Rudnicki, 2014; Comai
and Tajbakhsh, 2014). Different stimuli, such as injury or disease, are known to induce satellite cell
activation from quiescence and expansion as myoblasts; these cells will subsequently either exit the
cell cycle, differentiate and fuse to generate new muscle fibers (i.e., myogenesis) or undergo self-
renewal and return to quiescence to replenish the stem cell pool (Brack and Rando, 2012; Wang
et al., 2014).
The transcriptional regulation of muscle cell specification has been well characterized. Pax3 and
Pax7 are thought to be the principal regulators of muscle cell specification and tissue formation
during embryonic development. In adult satellite cells, whereas Pax7 is highly expressed, Pax3 is
only highly expressed in satellite cells of a subset of muscles, such as the diaphragm, but lowly
expressed in other muscles (Soleimani et al., 2012a). Recent studies analyzing the role of Pax7
in the maintenance and expansion of adult muscle stem cells have demonstrated that long-term
Pax7 ablation leads to the loss of adult satellite cells, which results in impaired muscle regeneration
after injury confirming that Pax7+ satellite cells are sufficient and required for adult muscle repair
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(Lepper et al., 2011; Sambasivan et al., 2011; von Maltzahn et al.,
2013; Brack, 2014). Furthermore, inactivation of Pax7 in satellite
cells of adult mice also leads to diminished heterochromatin
condensation (Gunther et al., 2013), suggesting a role for Pax7
in chromatin organization; of note, this has also been recently
proposed for Pax3 (Bulut-Karslioglu et al., 2012).
Satellite cells can be activated by many signals from the
regenerative microenvironment, including those mediated
by adhesion molecules, necrotic cues released from the
damaged fibers, or by growth factors and cytokines produced
by neighboring cells, including interstitial cells, resident
macrophages, fibroblasts, and microvasculature-related cells
(Giordani and Puri, 2013; Judson et al., 2013; Pannerec et al.,
2013; Brancaccio and Palacios, 2015). Several signaling cascades,
including the p38 mitogen-activated protein kinase (MAPK)
and the AKT pathways, can transmit these extracellular cues
to the myogenic cell nucleus (Cuenda and Cohen, 1999; Wu
et al., 2000; Keren et al., 2006; Serra et al., 2007), and regulate
expression and activity of the muscle-specific regulatory factors
(MRFs, that belong to the bHLH family of transcription factors:
Myf5, MyoD, myogenin and MRF4). In cooperation with
ubiquitously-expressed E proteins and myocyte enhancer factor
2 (MEF2) transcriptional regulators, MRFs bind to E-boxes and
MEF2-boxes of muscle promoters and induce the expression of
muscle-specific genes (Lluis et al., 2006; Singh and Dilworth,
2013; Segales et al., 2015). Satellite cell-dependent myogenesis
is also controlled by several epigenetic mechanisms, such
as chromatin remodeling, DNA methylation and covalent
modification of histones and transcription factors. The cross-talk
between the basic muscle-specific transcriptional and epigenetic
machineries allows the coordinated induction or repression
of distinct subsets of genes in order to advance through the
myogenic program (Dilworth and Blais, 2011; Segales et al.,
2015).
In this review, we will sum up the existing knowledge
about the transcriptional and epigenetic regulation of postnatal
myogenesis, describing the epigenetic status of adult muscle
stem cells and the changes in chromatin structure needed to
coordinately regulate the myogenic gene expression program.
We will also discuss the main signal transduction pathways that
transmit extracellular signals to the nucleus of myogenic cells,
focusing especially on the p38 MAPK pathway. Finally, we will
address how alterations in these signaling cascades contribute
to the reduced regenerative capacity of aged satellite cells and
whether this defect can be counteracted by pharmacological
manipulation of these pathways.
TRANSCRIPTIONAL AND TRANSLATIONAL
REGULATION OF MYOGENESIS
Myogenesis dependent on satellite cells is a well-defined multi-
step process characterized by the sequential activation of MRFs:
Myf5 and MyoD are expressed in undifferentiated proliferating
myoblasts, while myogenin and MRF4 are induced at the early
and late phases of differentiation, respectively (Sartorelli and
Caretti, 2005; Singh and Dilworth, 2013). Pax7 is expressed in
quiescent satellite cells and is also critical for their cell cycle
progression by regulating genes involved in cell proliferation,
while preventing differentiation (Olguin et al., 2007; Soleimani
et al., 2012a; von Maltzahn et al., 2013). Pax7-expressing
quiescent satellite cells induce the expression of Myf5 and
MyoD upon their activation (Mckinnell et al., 2008), thereby
allowing successive rounds of cell proliferation (Olguin and
Olwin, 2004); instead, downregulation of Pax7 prior to myogenin
activation facilitates exit the cell cycle and differentiation
entry (Olguin et al., 2007; Olguin, 2011; Bustos et al., 2015).
Translational control of MRFs’ expression also accounts for
the transition through the sequential myogenic stages: (1) In
quiescent satellite cells the expression of the Myf5 protein is
avoided by sequestration of the Myf5 mRNA in messenger
ribonucleoprotein granules and by the action of the microRNA-
31, which blocks Myf5 translation (Crist et al., 2012); (2) MyoD
protein expression is also prevented in quiescent satellite cells by
the action of tristetraprolin (TTP), a protein that promotes the
degradation ofMyoD RNA (Hausburg et al., 2015); (3)Moreover,
a global mechanism of repression of translation, mediated by
the phosphorylation of the eukaryotic initiation factor eIF2α at
serine 51, preserves the quiescent state of satellite cells, as cells
that cannot phosphorylate eIF2α exit quiescence and activate the
myogenic program (Zismanov et al., 2016).
Once MyoD mRNA has been correctly translated, the
initiation of the differentiation program requires the association
of MyoD with E proteins and their binding to E boxes of muscle
gene promoters, to activate their expression. This is actively
inhibited in proliferating myoblasts by different mechanisms.
Initially, in proliferating myoblasts, the formation of functional
MyoD/E protein heterodimers is prevented by the inhibitor of
differentiation (Id), an HLH protein that lacks the basic DNA-
binding domain and interacts with either MyoD or E proteins,
thus inhibiting myogenic differentiation. When myoblasts
exit the cell cycle Id expression is downregulated, allowing
functional heterodimers to be formed and promoting muscle
differentiation-specific gene expression (Puri and Sartorelli,
2000). Other proteins, such as the bHLH factors Twist,
masculine, Mist1, ZEB, Hey1, and I-mfa proteins, act as
repressors of MRFs either by direct association with them or
by sequestering their functional partners (Buas et al., 2010;
Siles et al., 2013). Moreover, in proliferating myoblasts, the
transcriptional repressor Snai1 excludes MyoD from muscle-
specific promoters. During differentiation, Snai1/2 expression is
downregulated by the action of two specific microRNAs, miR-
30 and miR-206, allowing access for MyoD to its target genes
(Soleimani et al., 2012b).
Interestingly, recent genome-wide analyses of MyoD binding
in C2C12 myogenic cells and primary myoblasts have revealed
that MyoD also binds to a large number of promoters of genes
that are not regulated during muscle differentiation, in both
myoblasts and myotubes (Cao et al., 2010; Soleimani et al.,
2012b). This genome-wide MyoD binding correlates with local
histone hyperacetylation, suggesting that MyoD could play a
role in reprogramming the epigenetic landscape by recruiting
histone acetyltransferases (HATs) to regions throughout the
genome.
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EPIGENETIC REGULATION OF
MYOGENESIS
As mentioned above, muscle gene expression is also regulated by
different epigenetic mechanisms, including DNA methylation,
chromatin remodeling, post-translational modifications of
histones and regulation by a network of noncoding RNA. These
epigenetic modifications are usually dynamic and reversible and
can be associated with gene activation or repression (reviewed in
Bergman and Cedar, 2013).
EPIGENETIC STATUS OF QUIESCENT
SATELLITE CELLS
The capacity to maintain quiescence is essential for the long-
term preservation of a functional stem cell pool in the majority
of tissues and organs. In stem cells, genes implicated in lineage
determination and progression are found in a poised state:
although transcriptionally silent, they contain active histone
marks that keep them prepared to be expressed after receiving
differentiation signals (Puri et al., 2015; Rumman et al., 2015). In
quiescent satellite cells, chromatin is kept in a transcriptionally
permissive state, with many genes harboring the activation
H3K4me3 mark at the transcription start sites (TSS), including
MyoD and Myf5, and a few number of genes labeled with the
inhibitory H3K27me3 mark (Liu et al., 2013). Thus, instead of
being only found on actively transcribed genes, the H3K4me3
mark is also present in inactive genes that will likely be
transcribed at later time points, for example, following satellite
cell activation (Guenther et al., 2007). Furthermore, Liu and
colleagues have also described that quiescent satellite cells
contain more than 1800 genes with their transcription start
site (TSS) marked by bivalent domains (e.g., both H3K27me3
and H3K4me3 marks), many of them corresponding to lineage-
specific genes (Mikkelsen et al., 2007). Of interest, in quiescent
satellite cells, the only myogenic transcription factor having
bivalent domains is Pax3 whereas, Pax7 is only marked by
H3K4me3 (Figure 1). In contrast, myogenin which is not
marked by either H3K4me3 or H3K27me3 in quiescent satellite
cells, shows a significant enrichment of the H3K4me3 mark
at its TSS upon cell activation (Liu et al., 2013). Together,
these data suggest an interplay between the Trithorax complex
(TrxG; responsible of H3K4me3) and the polycomb repressive
complexes (PRCs; responsible of H3K27me3). Additionally,
H3K9 methyltransferase PRDM2/RIZ, which is highly expressed
in quiescent satellite cells, binds to thousands of promoters in
G0 synchronized C2C12 myoblasts, including myogenic and cell
cycle regulators (Cheedipudi et al., 2015a,b). PRDM2 interacts
with Ezh2, the catalytic subunit of PRC2, and regulates its
association with a novel G0-specific bivalent domain identified
in the Ccna2 locus (Cheedipudi et al., 2015a). Ezh2, in turn,
is needed for homeostasis of the adult muscle stem cell pool
(Juan et al., 2011). Mice lacking Ezh2 specifically in satellite cell
have reduced muscle mass, fewer satellite cells post-birth, and
impaired regeneration following muscle injury. These differences
can be explained by defects in the proliferative capacity of satellite
cells (Woodhouse et al., 2013), and by impaired maintenance
and/or return to quiescence after injury (Juan et al., 2011).
Moreover, recent studies showed that preservation of muscle
stem cell quiescence is also dependent on the repression
of senescence pathways by Polycomb proteins (Sousa-Victor
et al., 2014a). Indeed, derepression of the senescence regulator
p16INK4a (Cdkn2a) in satellite cells of geriatric mice causes loss of
quiescence and entry into irreversible senescence, demonstrating
that the repression of Cdkn2a mediated by polycomb proteins is
needed to maintain the quiescent state of satellite cells in muscle
homeostatic conditions (revised in Sousa-Victor et al., 2015).
Additional methylation events regulate the activity of satellite
cells throughoutmyogenesis. One layer of epigenetic regulation is
performed by direct interaction of the arginine methyltransferase
Carm1 with Pax7. In quiescent satellite cells Carm1 binding to
Pax7 is inhibited; in contrast, when satellite cells are activated,
Carm1 interacts and methylates Pax7. Methylated Pax7 directly
binds to the Thritorax complex resulting in its recruitment to the
Myf5 promoter, leading to H3K4 methylation, Myf5 expression
and myogenic commitment (Kawabe et al., 2012). Finally, a
very recent study has shown that the histone methyltransferase
Suv4-20H1 is necessary to maintain satellite cell quiescence
by causing a condensed state of the heterochromatin through
the transcriptional repression of MyoD (Boonsanay et al.,
2016). Indeed, Suv4-20H1 binds directly to the MyoD Distal
Regulatory Region enhancer and catalyzes the transcriptionally
repressive H4K20me2 mark to enforce quiescence. Moreover,
ablation of Suv4-20H1 specifically in satellite cells resulted in
changes in chromatin structure accompanied by increasedMyoD
expression.
In addition to muscle injury, low stress exercise can also
activate satellite cells, via accelerated Wnt signaling (Fujimaki
et al., 2014). Indeed, the upregulation of canonical Wnt/β-
catenin signaling pathway modifies the structure of chromatin at
the Myod1 and Myf5 promoters, which results in an increased
expression of both genes and a higher number of proliferating
satellite cells. Of interest, in a recently published genome-
wide analysis of p38α binding at promoters, the Wnt signaling
pathway appeared as one of the principal signaling cascades
modulated by p38α (Segales et al., 2016). This finding highlights
the importance of p38α-dependent regulation of myogenesis,
since modulation of Wnt signaling has been shown to critically
regulate different aspects of satellite cell functions in vivo
(expansion, switching from proliferation to differentiation or cell
motility; Le Grand et al., 2009; Bentzinger et al., 2014; Murphy
et al., 2014).
Interestingly, several recent whole transcriptome analysis
of quiescent and proliferating muscle stem cells have shown
that the expression of DNA methyltransferases is deregulated,
since DNMT1 was markedly increased in activated satellite cells
compared to quiescent satellite cells, whereas DNMT3a and all
Tet isoforms were downregulated (Pallafacchina et al., 2010;
Liu et al., 2013; Ryall et al., 2015a). These observations suggest
that a regulation of the DNA methylation status, on top of
regulating differentiation (see below) may be critical for initiating
the MRF transcriptional program and/or regulating cell cycle in
the transition between quiescence and proliferation.
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FIGURE 1 | Transcriptional and epigenetic regulators of satellite cell quiescence, proliferation and differentiation. (Top) During homeostasis, quiescent
satellite cells express Pax7. Pax7 promoter is active, holding active chromatin marks, and being transcriptionally regulated by the Notch signaling pathway with the
Notch intracellular domain (NICD) interacting with the effector protein recombining binding protein-Jκ (RBPJκ) (Wen et al., 2012), and although not demonstrated,
probably populated by active chromatin remodelers and HATs. (Middle) In quiescent and proliferating satellite cells, muscle-specific gene promoters are repressed.
MyoD is associated with several repressors (like Id) and Sir2 in a complex that also contains pCAF. MyoD, YY1, and MEF2 factors recruit the PRC2 complex,
Suv39H1, and class I/II HDACs. DNMTs associate and methylate the DNA, and chromatin is populated with repressive histone marks. (Bottom) Upon differentiation
cues, transcriptionally active muscle-specific promoters contain active phosphorylated MyoD/E heterodimers, phosphorylated MEF2 dimers and SRF transcription
factors. In collaboration with arginine methyltransferases Prmt4/5, the SWI/SNF remodeling complex, HATs and Thritorax complexes will be recruited. DNA will be
demethylated, and chromatin acetylated and populated with active histone marks.
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EPIGENETIC REPRESSION OF THE
MYOGENIC-DIFFERENTIATION GENE
PROGRAM IN PROLIFERATING SATELLITE
CELLS
Epigenetic events are crucial to maintain satellite cells in a
quiescent or proliferating state and prevent their premature
differentiation (Figure 1). DNA methylation is thought to be
one of the main repressive systems acting on muscle gene
loci (reviewed in Carrio and Suelves, 2015; Laker and Ryall,
2016). Indeed, DNA methyltransferase inhibitors (such as 5-
azacytidine) can induce the transdifferentiation of fibroblasts
into myoblasts (Taylor and Jones, 1979; Lassar et al., 1989);
moreover, treatment of C2C12 myoblasts with 5-azacytidine
promotes myogenesis, resulting in myotubes with enhanced
maturity as compared to myotubes from untreated cells (Hupkes
et al., 2011). Whereas the DNA methylation status of quiescent
satellite cells has not been investigated in high detail, it has
been shown that, when myoblasts differentiate into myotubes, a
subset of genes display changes in their DNA methylation status,
most of them becoming hypomethylated (Carrio et al., 2015).
Other studies have proved that DNAmethylation helps to restrict
myogenin activation until both MEF2A and SIX1 transcription
factors are co-expressed, in embryonic myogenesis and in adult
myoblasts, and that binding of SIX1 and MEF2A is required
for demethylation at the myogenin locus (Palacios et al., 2010b).
Additionally, Ezh2 targets the DNAmethyltransferases DNMT3a
and DNMT3b to specific genes, thus linking the two repressive
mechanisms: DNA and histone methylation (Vire et al., 2006).
However, it is still unclear how DNA methylation is regulated
during myogenesis or if this regulation affects only a subset of
genes. A recent study showed the presence of 5-methylcytosine
and 5-hydroxymethylcytosine within specific gene regions of the
Notch signaling pathway in myoblasts, myotubes and mature
skeletal muscle (Terragni et al., 2014). Notch signaling is crucial
for the regulation of several developmental stages, including the
quiescence and proliferative states of satellite cells (Bjornson
et al., 2012; Mourikis et al., 2012; Qin et al., 2013). Terragni
et al. identified that several Notch signaling genes, such as
Notch1 and its ligands Dll1 and Jag2 were hypomethylated and
hydroxymethylated in skeletal muscle lineages, and propose
that hypomethylation and/or hydroxymethylation could directly
regulate the expression of these genes, thus placing key
myogenic processes regulated by Notch signaling (e.g., satellite-
cell maintenance and self-renewal; see Mourikis and Tajbakhsh,
2014) under epigenetic control (Terragni et al., 2014). Therefore,
is crucial to determine how these modifications are regulated
by specific DNA methyltransferases and demethylases that act
during myogenesis.
Another important epigenetic mechanism to repress
muscle-differentiation gene expression is the post-translational
modification of histones. In proliferating satellite cells, the
promoters of genes important for muscle differentiation
contain histones that are hypoacetylated and marked with
H3K9me2, H3K9me3, and H3K27me3. These repression marks
are catalyzed by histone deacetylases (HDACs) and histone
lysine methyltransferases from the PcG and Suv39H1 families
(Palacios and Puri, 2006; Segales et al., 2015). In proliferating
myoblasts, the transcriptional regulator Ying Yang 1 (YY1)
recruits the histone H3K27 methyltransferase Ezh2 to muscle
genes promoters, thus preventing their expression (Caretti et al.,
2004). Another lysine methyltransferase, G9a, catalyzes the
repressive H3K9me2 mark on MyoD target promoters and also
directly methylates MyoD at lysine 104 (K104) to repress its
transcriptional activity (Ling et al., 2012).
Muscle-specific gene expression can also be repressed by the
action of HDACs, which remove acetyl groups from histone tails
and also maintain transcription factors in a deacetylated state.
In the absence of promyogenic signals, class I HDACs interact
with MyoD and several members of class II HDACs interact
with MEF2 repressing its activity, thus avoiding premature
expression of skeletal muscle differentiation genes (Lu et al.,
2000). Moreover, there is another class of HDACs called Sirtuins
(or class III HDACs; Sir2), whose activity depends on NAD+
levels and forms a repressor complex with pCAF and MyoD,
suggesting that Sir2 works as a redox-sensor regulating muscle-
specific genes expression in response to metabolic changes (Fulco
et al., 2003). Gene transcription can also be regulated by other
chromatinmodifications, such as by switching canonical histones
with histone variants or expressing specific histone isoforms
in a cell type-specific manner (Happel and Doenecke, 2009).
For instance, in undifferentiated myoblasts, MyoD expression
is repressed by the homeobox protein Msx1, that interacts with
the repressive histone methyltransferase G9a and also binds
specifically to the histone variant H1b, which is enriched at the
core enhancer region ofMyod1 (Lee et al., 2004).
EPIGENETIC REGULATION OF SKELETAL
MUSCLE DIFFERENTIATION
For myogenic differentiation to take place, the expression of
the differentiation-inhibitory gene program operating during
myoblast proliferation has to be repressed. In fact, several cell
cycle inactivating mechanisms are known act together with
early muscle differentiation events. For instance, cell cycle
exit is regulated by the retinoblastoma protein pRb, which
represses the E2F transcription factors and its implicated in
the recruitment of H3K9me3 and H3K27me3 methyltransferases
at cell cycle-associated genes (Blais et al., 2007). Furthermore,
the small chromatin-binding protein p8, which interacts with
MyoD, the histone acetyltransferase p300 and the RNA helicase
p68, negatively regulates the cell cycle and promotes myogenic
differentiation (Sambasivan et al., 2009). Additionally, in
myoblasts that are induced to differentiate, Pax7 promoter
presents increased levels of H3K27me3 repression mark,
mediated by Ezh2 (Palacios et al., 2010a).
Following reception of differentiation-promoting signals, the
epigenetic pattern of muscle-specific genes is quickly modified,
and the Polycomb-mediated repressive H3K27me3 marks are
substituted by the transcriptionally permissive H3K4me3 mark
(Figure 1). H3K27me3 removal is mediated by the histone
demethylase UTX, which can be recruited to muscle specific
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loci by the homeodomain transcription factor Six4 and/or the
histone chaperone Spt6 (Seenundun et al., 2010; Wang et al.,
2013). Importantly, a very recent study using UTX specific
deletion in satellite cells demonstrated that demethylation of
H3K27 is required for myofiber regeneration (Faralli et al., 2016).
Indeed, the demethylase activity of UTX has been proved to be
necessary for myogenin expression, which leads to differentiation
of myoblasts. Thereby, the authors uncovered a crucial role for
the enzymatic activity of UTX in muscle-specific gene activation
during tissue regeneration, and a physiological role for active
H3K27 demethylation in vivo (Faralli et al., 2016). In parallel,
the combined action of histone demethylases KDM1A/LSD1A
and JMJD2A/KDM4A permits the removal of the H3K9me2/3
repressive marks deposited by KMT1A/Suv39h1 in proliferating
myoblasts (Choi et al., 2010; Verrier et al., 2011). Moreover, the
expression of several key repressors of transcription, such as the
H3K27 methyltransferase Ezh2 and the H3K9 methyltransferase
G9a, is downregulated at the onset of muscle differentiation
(Asp et al., 2011; Ling et al., 2012). On the other hand,
through its association with p38-phosphorylated MEF2D, the
TrxG complex is recruited to muscle-specific promoters, such
as myogenin and Ckm, and deposits the transcriptionally
permissive mark H3K4me3 (Rampalli et al., 2007; Mckinnell
et al., 2008). Other histone methyltransferases are also involved
in myogenesis regulation; for instance, expression of the H3K4
histone methyltransferase Set7/9 increases during differentiation,
and this is required to express muscle contractile proteins and for
myofibril assembly (Tao et al., 2011). In addition, Set7/9 interacts
with MyoD to enhance the expression of muscle-specific genes
and prevents H3K9 methylation at muscle promoters mediated
by Suv39h1. Thus, many mechanisms seem to work coordinately
to efficiently remove the transcriptionally-repressive marks.
In undifferentiated myoblasts, muscle gene promoters are
partially occupied by inactive transcription factors forming a
complex with HDACs and HATs. Active HDACs and Sirtuins
deacetylate HATs and inhibit their acetyltransferase activity,
as demonstrated for Sirt2 and pCAF/Kat2b (Fulco et al.,
2003). Importantly, the redox balance of the myoblast can
regulate Sirt2 activity: upon receiving differentiation signals, its
[NAD+]/[NADH] ratio decreases, leading to Sirt2 inhibition
and enabling pCAF to acetylate several target proteins including
histones, MyoD and MEF2 (Sartorelli and Caretti, 2005). In a
recent study, a role in the regulation of myoblast differentiation
has been ascribed to Sirt3, a mitochondrial NAD+ dependent
deacetylase (Abdel Khalek et al., 2014). Sirt3 expression
increases when C2C12 cells reach confluence and is maintained
elevated during differentiation. Indeed, depletion of Sirt3 blocks
differentiation, causing high levels of ROS and a decreased
manganese superoxide dismutase activity (Abdel Khalek et al.,
2014). Notably, sirtuins have also been found to play an
important role during muscle stem cell activation, when satellite
cells undergo a metabolic switch from fatty acid oxidation to
glycolysis. This metabolic reprogramming is associated with
reduced intracellular NAD+ levels and lower activity of the
histone deacetylase Sirt1, which leads to increased H4K16
acetylation and induction of muscle gene transcription (Ryall
et al., 2015b). Furthermore, mice with muscle-specific ablation
of the Sirt1 deacetylase domain have smaller myofibers and
impaired muscle regeneration. Of note, the IGF1/AKT signaling
pathway leads to p300 phosphorylation, which promotes its
interaction with MyoD and the acetylation of muscle gene
promoters (Serra et al., 2007). Thereby, the inhibition of HDACs
and Sirtuins is coupled to HAT activation, which results in the
activation of muscle transcription factors in response to different
extracellular cues. Recent studies have also demonstrated that,
upon differentiation, the HAT p300 is recruited at distinct Myod1
regulatory regions, resulting in an increased histone acetylation
(Hamed et al., 2013). The authors also show that p300 directly
participates in the early regulation of Myod1 enhancer, and shed
light on how p300 histone acetyltransferase activity is associated
to enhancer activation and, consequently, gene transcription
(Hamed et al., 2013).
Chromatin remodeling is also essential for myogenesis,
as illustrated by the recruitment of the SWI/SNF chromatin
remodeling complex to muscle-specific loci, which depends
on p38 MAPK activity (Simone et al., 2004). MyoD and the
SWI/SNF subunit BAF60c are found to the promoters of MyoD
target genes in myoblasts, previous to activation of transcription,
while the ATPase subunit Brg1 is recruited only when cells are
induced to differentiate, thus allowing chromatin remodeling and
muscle genes transcription (Forcales et al., 2012). Furthermore,
the histone arginine methyltransferases Prmt5 and Carm1 are
also involved in the recruitment of the SWI/SNF complex to
different muscle gene promoters, such as myogenin and Ckm
(Dacwag et al., 2009). Interestingly, it has been recently shown
that the regulatory sequences of genes expressed at late time
points of myogenesis lie in close physical proximity, despite
these genes being located on different chromosomes (Harada
et al., 2015). Of note, formation of these inter-chromosomal
interactions requires MyoD as well as functional Brg1. The late
myogenic gene interactions are associated with the repression of
these genes at early times of differentiation, suggesting that this
higher-order chromatin organization constitutes a mechanism
that contributes to temporal regulation of gene expression during
muscle differentiation (Harada et al., 2015).
There is increasing evidence indicating that the substitution
of canonical histones with histone variants can also regulate
gene expression and muscle differentiation. For instance, the
chromatin-remodeling complex SNF2-related CBP activator
protein (SRCAP) modulates the replacement of histone H2A for
the H2A.Z variant, which is associated with active transcription.
At the onset of skeletal muscle differentiation, the SRCAP subunit
p18Hamlet, which deposites H2A.Z on chromatin, is recruited
to the myogenin promoter in a p38 MAPK-dependent manner
(Cuadrado et al., 2010). Additionally, upon induction of muscle
differentiation, the canonical histone H3 is cleaved and the
histone chaperones Asf1 and HIRA recruit the variant histone
H3.3 to the Myod1 promoter, allowing MyoD transcriptional
activation. Moreover, histone H3.3 is deposited at myogenin
and other muscle-specific promoters thanks to other histone
chaperone, Chd2, and MyoD itself (Yang et al., 2011; Harada
et al., 2012). Another histone variant that has been proved
to be essential for the activation of the myogenic program
is the macroH2A1.2 (mH2A1.2), which is characterized by
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the presence of a ∼25 kDa evolutionarily conserved carboxyl-
terminal domain called the macro domain. Indeed, activation of
muscle enhancers is dependent on mH2A1.2, as it regulates both
H3K27 acetylation and recruitment of the transcription factor
Pbx1 at prospective enhancers (Dell’orso et al., 2016).
THE p38 MAPK SIGNALING PATHWAY
Cell response to external stimuli requires the integration
and activation of intracellular mediators and effectors
and signal transduction mechanisms, which strongly
depend on post-translational modifications of proteins,
among which phosphorylation is particularly relevant.
A paradigm of intracellular signaling is the activation of
mitogen-activated protein kinases (MAPKs), as they seem to
participate in most signal transduction pathways. The MAPK
superfamily of intracellular serine/threonine protein kinases
is evolutionary conserved, and in mammals it principally
includes the extracellular signal regulated kinases (ERKs),
the c-Jun N-terminal kinases/stress activated protein kinases
(JNKs/SAPKs), the p38 MAPKs, the ERK5 or big MAPKs and
atypical MAPKs like ERK3/4, ERK7, and Nemo-like kinase
(NLK) (Reviewed in Cargnello and Roux, 2011).
p38, a subgroup of the MAPKs, was firstly described as a
transducer of the response to environmental stress conditions
and as a critical mediator of inflammatory cytokines, but
many different non-stress stimuli can also activate p38 MAPK
signaling, leading to the regulation of multiple cellular processes,
including senescence, apoptosis, cell-cycle arrest, regulation of
RNA splicing, tumor development or differentiation of various
cell types such as neurons, adipocytes, cardiomyocytes and
myoblasts (reviewed in Cuenda and Rousseau, 2007; Igea and
Nebreda, 2015). Mammalian cells have four p38 MAPK family
members: MAPK14 (p38α), MAPK11 (p38β), MAPK12 (p38γ),
and MAPK13 (p38δ). p38α is ubiquitously expressed usually at
high levels, whereas p38β is expressed at lower levels and p38γ
and p38δ have more restricted expression patterns (Cuenda and
Rousseau, 2007; Cuadrado and Nebreda, 2010). All p38 MAPKs
are phosphorylated and activated by the MAPK kinase MKK6.
Others p38 MAPK kinases are MKK3, which activates p38α,
p38γ, and p38δ, and MKK4 that in some cases can activate p38α.
Once activated, p38 MAPKs phosphorylate serine/threonine
residues of their substrates, which include several transcription
factors as well as protein kinases (see Zarubin and Han,
2005). The identification of physiological substrates for p38α
and p38β has been facilitated by the availability of specific
pyridinyl imidazole inhibitors, such as SB203580/SB202190 and
the reported inhibitor of the four p38 isoforms (BIRB0796)
(Kuma et al., 2005; Bain et al., 2007). More than 100 proteins have
been found to be directly phosphorylated by p38α and many of
them are implicated in the regulation of gene expression (Cuenda
and Rousseau, 2007; Cuadrado and Nebreda, 2010). In addition,
the p38α pathway can regulate the production of extracellular
signaling molecules, such as cytokines, chemokines, and growth
factors. Recent reports have provided evidence for a dual role of
p38α in regulating cancer progression, as, depending on the cell
type and the tumoral stage, it can act either as tumor suppressor
or as tumor promoter by facilitating tumor cell survival in
response to chemotherapeutic treatments (Reviewed in Igea and
Nebreda, 2015).
MAPKs activation has also been related to the differentiation
capacity of various stem cell types. Particularly, the p38 pathway
acts as one of the main controllers of muscle stem cells’ fate
decisions (Keren et al., 2006; Lluis et al., 2006; Segales et al.,
2015). Indeed, several studies recapitulating myogenesis in vitro
using different cellular models (myoblast cell lines or satellite
cell-derived primary myoblasts) have demonstrated an active
role of the p38 MAPK pathway in each myogenic stage, where
its function as a regulator of the myoblast proliferation-to-
differentiation transition is particularly relevant, as p38 induces
cell cycle withdrawal and the expression of muscle-specific genes
(Keren et al., 2006; Lluis et al., 2006; Liu et al., 2012; Doles and
Olwin, 2015; Segales et al., 2015).
p38 MAPK SIGNALING IN SATELLITE
CELL-DEPENDENT MYOGENESIS
Different stimuli can activate p38 MAPK in satellite
cells, including inflammatory cytokines, such as TNF or
amphoterin/HMGB1, growth factors such as TGFβ or cell-to-cell
contact (reviewed in Guasconi and Puri, 2009; Krauss, 2010).
The role of p38 MAPKs pathway during myogenesis has been
extensively studied, especially in vitro. Pioneer studies from the
groups of Cuenda, Bengal and Puri showed the requirement
of this pathway for myogenic differentiation in vitro through
distinct mechanisms (Cuenda and Cohen, 1999; Zetser et al.,
1999; Wu et al., 2000). It has been proven that p38α turns
off the proliferation-promoting JNK pathway by upregulating
the JNK phosphatase MKP-1 leading to downregulation of
cyclin D1 expression, cell cycle exit and allowing the onset of
muscle differentiation (Perdiguero et al., 2007b). Besides this,
independent studies have shown that the p38 MAPK signaling
pathway is a critical regulator of skeletal muscle differentiation
and fusion. In fact, the fusion of myoblasts into myotubes
and the induction of muscle-specific genes are prevented by
treatment with the p38α/β inhibitors, whereas forced activation
of p38 MAPK by ectopic expression of a constitutively active
mutant of MKK6 is sufficient to override the inhibitory factors
present in proliferating cells and to induce both the expression
of differentiation markers and the appearance of multinucleated
myotubes (Lluis et al., 2006). Notably, in vitro studies using
satellite cells lacking individual p38 family members showed
that the four p38 isoforms are not completely redundant during
myogenesis, and uncovered a predominant role of the p38α
isoform in myogenic differentiation and fusion (Ruiz-Bonilla
et al., 2008; Wang et al., 2008; Liu et al., 2012), with p38α
regulating the whole myogenic gene expression program at
multiple steps (see below) and promoting myoblast fusion
by upregulation of tetraspanin CD53 (Liu et al., 2012), with
p38γ signaling contributing to proliferation by preventing
premature differentiation through induction of a repressive
MyoD transcriptional complex (Gillespie et al., 2009), whereas
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p38β and p38δ seemed to be dispensable for these processes
(Perdiguero et al., 2007a; Ruiz-Bonilla et al., 2008).
Importantly, p38α/p38β are also required for activation of
quiescent satellite cells and MyoD induction (Jones et al., 2005).
Moreover, when satellite cells are activated, signaling by p38α
leads to inactivation of tristetrapolin (TTP) and stabilization
of MyoD RNA (Hausburg et al., 2015). Activated satellite cells
enter the cell cycle and a subset undergoes asymmetric division
to replenish the muscle stem cells pool. Interestingly, it has
been recently published that p38α/β MAPK are asymmetrically
activated in only one daughter cell, in which MyoD is induced,
allowing cell cycle entry and generating a proliferating myoblast.
In contrast, MyoD induction is prevented in the other daughter
cell by the absence of p38α/β MAPK signaling, renewing the
quiescent satellite cell pool (Troy et al., 2012).
A role of p38α in skeletal muscle growth and regeneration
in vivo has also been reported. Using conditional satellite cell
p38α-null mice the authors confirmed previous in vitro studies
and demonstrated that p38α restrains postnatal proliferation and
promotes timely myoblast differentiation (Brien et al., 2013).
p38α ablation caused a postnatal growth defect together with an
augmented number of satellite cells, due to increased progenitor
proliferation postnatally. Moreover, muscle regeneration after a
cardiotoxin-induced injury was delayed in the absence of p38α,
with further enhancement of the satellite cell population (Brien
et al., 2013). The absence of p38α was accompanied by increased
p38γ phosphorylation, and p38γ inhibition ex vivo significantly
diminished the myogenic defect. As muscle regeneration in vivo
can occur quite effectively in the absence of p38γ (Ruiz-Bonilla
et al., 2008), but is defective in the absence of p38α (Brien et al.,
2013), p38α arises as the master kinase for reprogramming gene
expression during proliferation-to-differentiation transition of
satellite cells, both in vitro and in vivo.
Similar to mice, an essential role for p38 MAPK has been
demonstrated in the regulation of human satellite cells (huSCs)
regenerative capacity (Charville et al., 2015). The authors found
that p38 was upregulated in activatedmuscle stem cells compared
with quiescent satellite cells. Moreover, reversible inhibition of
p38 in cultured human satellite cells prevented differentiation
and promoted expansion of huSCs. These expanded satellite cells
showed an enhanced self-renewal and engraftment potential in
comparison to freshly isolated satellite cells or cells cultured
without p38 inhibitors.
p38 MAPK SIGNALING IN THE
TRANSCRIPTIONAL AND EPIGENETIC
REGULATION OF MYOGENESIS
p38 MAPK pathway is crucial for the onset of muscle
differentiation, as it modulates the expression and/or activity of
many of the players involved in the transcriptional and epigenetic
regulation of myogenesis (Figure 2). p38α/β MAPKs promote
MEF2 transcriptional activity and MyoD/E47 heterodimer
formation by direct phosphorylation of MEF2 and E47 (Zetser
et al., 1999; Lluis et al., 2005), which in turn enhances RNA Pol II
recruitment to myogenic loci, thus initiating the differentiation
program. Furthermore, by phosphorylating the chromatin-
associated protein BAF60c, p38α/β kinases contribute to the
assembly of the myogenic transcriptosome on the chromatin
of muscle loci by promoting the recruitment of SWI/SNF
chromatin remodeling complex (Simone et al., 2004; Serra et al.,
2007; Forcales et al., 2012), and ASH2L-containing mixed-
lineage leukemia (MLL) methyltransferase complex (Rampalli
et al., 2007). Through phosphorylation, p38α also recruits SNF2-
related CBP activator protein (SRCAP) subunit p18Hamlet to
muscle loci, which is in turn required for H2A.Z accumulation
and transcriptional activation (Cuadrado et al., 2010).
p38α can also repress the expression of Pax7 in differentiating
muscle stem cells by phosphorylation of Ezh2, which promotes
the interaction between YY1 and PRC2 creating repressive
chromatin on the Pax7 promoter, therefore regulating the
decision of satellite cells to proliferate or differentiate (Palacios
et al., 2010a; Mozzetta et al., 2011). By contrast, activation of
p38γ in satellite cells suppresses MyoD transcriptional activity
by direct phosphorylation, via association with the H3K9
methyltransferase KMT1A, thus also affecting this myogenic
decision (Gillespie et al., 2009). Moreover, two recent studies
have shown that that activation of p38α/β downstream kinase
Msk1, via phosphorylation of serine 28 on histone H3, regulates
a chromatin exchange between Ezh2- and Ezh1-containing
PRC2 complexes at the onset of differentiation (Stojic et al.,
2011; Mousavi et al., 2012). Interestingly, downregulation of
Ezh1blocks MyoD recruitment to the myogenin promoter,
thereby impairing muscle differentiation. Furthermore, in
differentiating myoblasts, Ezh1-containing complexes have also
been associated to Pol II recruitment and transcriptional
activation, questioning the prevalent view of PRC2 complexes
as chromatin repressors (Mousavi et al., 2012). Thus, depending
on the engagement of specific p38 isoforms, the p38 MAPK
pathway can either induce or repress gene expression in
satellite cells, Interestingly, in addition to all these nuclear
functions, p38α has been recently shown to have an unexpected
set of cytoplasmic substrates during myoblast differentiation,
probably implicated in its own activation (Knight et al.,
2012).
In response to osmotic stress, Hog1, the p38 MAPK homolog
in yeast, has been shown to activate transcription by acting
directly at chromatin (De Nadal et al., 2004; Pokholok et al.,
2006). Equally, upon exposure to different kind of stresses,
mammalian p38 MAPK can bind to some stress-responsive
loci, highlighting that the interaction of the MAPK with
target promoters can induce gene expression (Ferreiro et al.,
2010). During myogenic differentiation, p38α has also been
found to bind certain muscle-specific genes such as myogenin,
muscle creatine kinase, and myosin heavy chain (Simone et al.,
2004; Palacios et al., 2010a). Importantly, it has been recently
demonstrated that p38α exerts its promyogenic function at
least in part by binding and acting at chromatin (Segales
et al., 2016). Genome-wide localization analysis linked to gene
expression profiling have shown that p38α binds to a large
number of active promoters during the myoblast proliferation-
to-differentiation transition, confirming the importance of kinase
signaling pathways in directly regulating transcription (Segales
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FIGURE 2 | Roles of p38 MAPKs in satellite cell-driven myogenesis. (Top) Satellite cells in adult muscles are in a quiescent state. Upon injury, satellite cells are
activated, undergo asymmetric division and generate a self-renewing daughter cell and a committed progenitor or myoblast which enters the cell cycle. Myoblasts
proliferate, differentiate and fuse to form myotubes and new myofibers during adult muscle regeneration. Canonical markers for each stage are indicated-(Bottom)
Known substrates and regulated processes by p38α/β and p38γ MAPKs during the different stages of myogenesis. Direct substrates are indicated in red. Linked
processes are boxed in gray or black.
et al., 2016), in agreement with previous reports for other
related kinases (Bungard et al., 2010; Tiwari et al., 2012; Di
Vona et al., 2015). Interestingly, p38α was also associated to
promoters that were transcriptionally inactive or repressed at
the onset of differentiation (Segales et al., 2016). Thus, p38α
is recruited to a large set of myogenic gene promoters to
facilitate their activation or repression, hence pointing to more
complex regulatory mechanisms than previously anticipated.
How is p38α recruited to muscle loci is not known, but it
likely involves interaction with chromatin-regulatory and/or
transcription factors, as demonstrated for several stress-induced
genes (Ferreiro et al., 2010). Of interest, p38α-bound promoters
are enriched with binding motifs for several transcription factors,
principally Sp1, Tcf3/E47, Lef1, FoxO4,MyoD, andNFATc, which
are known to be phosphorylation substrates of p38 MAPK
(Segales et al., 2016).
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p38 MAPK REGULATION OF MUSCLE
STEM CELL FUNCTIONS DURING AGING
Aging is associated with an alteration of organism homeostasis
and a progressive decline of tissue functions (Oh et al., 2014).
Particularly, in skeletal muscle, mass and strength decline with
aging (a process called sarcopenia), which is also linked to a
progressive loss of muscle stem cells regenerative capacity. Age-
related dysfunction of muscle regeneration has been attributed to
both extrinsic alterations in the regenerative microenvironment
and to satellite cell-intrinsic mechanisms (recently reviewed in
Garcia-Prat et al., 2013; Blau et al., 2015; Brack and Munoz-
Canoves, 2015; Sacco and Puri, 2015; Sousa-Victor et al., 2015).
Indeed, whereas parabiosis (a process whereby the circulatory
system of two living organisms is surgically joined), and whole
muscle grafting experiments in mice proved that alterations in
the regenerative environment of aged muscles regulate stem
cell function (Conboy et al., 2005; Brack et al., 2007), data
from recent studies using transplantation of purified satellite
cells support cell-intrinsic deficits with aging (Chakkalakal et al.,
2012; Bernet et al., 2014; Cosgrove et al., 2014; Price et al.,
2014; Tierney et al., 2014; Sousa-Victor et al., 2014a,b; Garcia-
Prat et al., 2016). These cell-intrinsic functional deficits can
include DNA and oxidative damage, impaired mitochondrial
function and alterations of the epigenetic profile, such as post-
translational histone modifications or changes in the DNA
methylation patterns. In this regard, a progressive increase in
DNA methylation in aging muscle has been recently reported
(Ong and Holbrook, 2014; Zykovich et al., 2014) and it has
also been described that muscle stem cells isolated from aged
mice show alterations both in the levels and distribution of the
H3K27me3 chromatin mark (Liu et al., 2013). At the level of
single genes, the promoter of INK4a, which encodes the cell cycle
inhibitor and marker of senescence p16INK4a, is epigenetically
repressed in young quiescent satellite cells via ubiquitination
of histone H2A; a mechanism deregulated in geriatric cells,
which highly express p16INK4a and undergo a transition to
a presenescent state. This conversion from quiescence to
senescence is a hallmark of geriatric satellite cells, and it can
be reversed through the downregulation of p16INK4a expression,
which also restores the self-renewal capacity of satellite cells
(Sousa-Victor et al., 2014a,b). In human geriatric satellite cells
p16INK4a is upregulated, so these findings are particularly relevant
for stem-cell rejuvenation in sarcopenic muscles.
Contrary to other types of stem cells, such as hematopoietic
stem cells, both the function and the number of satellite
cells decline with aging, compromising the recovery capacity
of sarcopenic muscles in response to injury (Brack et al.,
2005; Chakkalakal et al., 2012; Sousa-Victor et al., 2014b).
Whether satellite cell decline might contribute to age-associated
loss of muscle mass in the absence of muscle damage is
a matter of active debate. By depleting satellite cells in
young sedentary animals, one study showed that these cells
do not contribute to the maintenance of muscle size or
fiber type composition during aging, but that their loss may
contribute to age-related muscle fibrosis (Fry et al., 2015).
Through genetic lineage experiments, another study showed
that even in the absence of injury, satellite cells contribute
to myofibers in all adult muscles, although the extent and
timing differed (Keefe et al., 2015). However, genetic ablation
experiments in this latter study showed that satellite cells are not
globally required to maintain myofiber size of uninjured adult
muscle.
Several signaling pathways have been found altered in
satellite cells from aged mice, among them fibroblast growth
factor receptor-1 (FGFR1), p38 MAPK, and JAK/STAT, thus
contributing to impaired control of quiescence and compromised
self-renewal capacity (Bernet et al., 2014; Cosgrove et al., 2014;
Price et al., 2014; Tierney et al., 2014).
There is clear evidence that during aging the FGFR1 signaling
pathway is altered. It has been suggested that increased FGF2
signaling in aged muscle can cause the disruption of satellite
cell quiescence (Chakkalakal et al., 2012). In more recent studies
it has been proposed that the augmented FGF2 in the aged
satellite cell niche constitutes a mechanism to compensate for
the loss of FGFR1 signaling. Furthermore, alterations in FGF2
signaling, together with elevated levels of TNF observed in
old muscles, have been associated to constitutive and aberrant
activation of the p38 MAPK pathway, which leads to impaired
self-renewal of aged muscle stem cells (Bernet et al., 2014).
Indeed, it has been proved by two different groups that
this aberrant activation of the p38 MAPK in aged satellite
cells interferes with asymmetric division, resulting in highly
reduced self-renewal and regenerative capabilities. Interestingly,
pharmacological inhibition of p38α/β can partially restore the
proliferative capacity and self-renewal of aged muscle stem cells
as assessed in muscle transplantation experiments (Bernet et al.,
2014; Cosgrove et al., 2014). Of note, the advantageous effects of
p38α/β MAPKs neutralization were strongly enhanced if satellite
cells treated with p38 MAPK chemical inhibitors were cultured
in a hydrogel matrix, mimicking the biomechanical properties
of young muscles, thus providing the basis for improving stem
cell engraftment for muscle regeneration in aged individuals
(Cosgrove et al., 2014).
Finally, the reduced regenerative potential of aged muscle
stem cells has also been correlated with increased JAK/STAT
signaling, which impairs satellite cell function by stimulating
asymmetric division (Price et al., 2014). Moreover, IL-6-activated
STAT3 regulates the expression of the myogenic factor MyoD,
promoting differentiation of satellite cells in detriment to
their expansion (Tierney et al., 2014). Thus, these studies
evidence that intracellular signaling pathways, such as JAK-
STAT and p38 MAPK might play distinct age-dependent roles in
myogenesis.
PERSPECTIVE
As discussed in this review, an emerging concept in the field
of myogenesis is that the cell-intrinsic signaling networks that
are activated in response to external cues are dysregulated in
satellite cells with aging. One paradigm of this age-dependent
dysregulation is the p38 MAPK signaling pathway. While it is
transiently required for the activation, cessation of proliferation
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and initiation of the myogenic-differentiation gene program of
adult satellite cells, thus playing an important positive role for
muscle regeneration in the adult, its persistent activation in aged
satellite cells has deleterious consequences on the functionality of
these cells, thus impairing efficient regeneration with aging. Thus,
identifying the epigenetic and transcription drivers and targets of
the p38 MAPK pathway (and of other major myogenic signaling
cascades) will be key to shed light on the complex regulation of
myogenesis throughout life, and will facilitate the identification
of molecular targets that can be druggable for intervening in
muscle aging and disease, in order to enhance regeneration of
degenerating muscle in both conditions.
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